Norinchukin Bank The raised its stake in Zoetis Inc (NYSE:ZTS) by 35.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 91,061 shares of the company’s stock after purchasing an additional 24,031 shares during the quarter. Norinchukin Bank The’s holdings in Zoetis were worth $6,560,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Zoetis in the 4th quarter valued at $108,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Zoetis in the 3rd quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its holdings in shares of Zoetis by 251.9% in the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock valued at $121,000 after purchasing an additional 1,360 shares during the last quarter. Shine Investment Advisory Services Inc. boosted its holdings in shares of Zoetis by 86.5% in the 3rd quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock valued at $143,000 after purchasing an additional 1,040 shares during the last quarter. Finally, Advisory Services Network LLC boosted its holdings in shares of Zoetis by 42.4% in the 4th quarter. Advisory Services Network LLC now owns 2,423 shares of the company’s stock valued at $175,000 after purchasing an additional 721 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.
A number of equities analysts have recently commented on ZTS shares. Barclays set a $77.00 target price on shares of Zoetis and gave the company a “hold” rating in a research note on Saturday. Deutsche Bank raised their target price on shares of Zoetis from $76.00 to $78.00 and gave the company a “hold” rating in a research note on Friday. Piper Jaffray Companies set a $88.00 target price on shares of Zoetis and gave the company a “buy” rating in a research note on Friday. Stifel Nicolaus reissued a “buy” rating and issued a $86.00 target price (up previously from $84.00) on shares of Zoetis in a research note on Friday. Finally, Bank of America raised their target price on shares of Zoetis from $80.00 to $87.00 and gave the company a “buy” rating in a research note on Friday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $79.83.
Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, February 15th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.03. Zoetis had a net margin of 16.28% and a return on equity of 65.96%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter in the previous year, the firm posted $0.47 EPS. The firm’s quarterly revenue was up 14.3% on a year-over-year basis. analysts expect that Zoetis Inc will post 3.02 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 1st. Investors of record on Friday, April 20th will be paid a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.63%. The ex-dividend date is Thursday, April 19th. Zoetis’s dividend payout ratio (DPR) is 28.57%.
ILLEGAL ACTIVITY NOTICE: “Zoetis Inc (ZTS) Shares Bought by Norinchukin Bank The” was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://www.chaffeybreeze.com/2018/02/19/zoetis-inc-zts-shares-bought-by-norinchukin-bank-the.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.